# A Clinical Investigation to Confirm the Ability of MammoWave in Breast Lesions Detection

> **NCT05300464** · NA · RECRUITING · sponsor: **Umbria Bioengineering Technologies** · enrollment: 600 (estimated)

## Conditions studied

- Breast Cancer

## Interventions

- **DEVICE:** Clinical investigation medical device class IIa marked CE

## Key facts

- **NCT ID:** NCT05300464
- **Lead sponsor:** Umbria Bioengineering Technologies
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-01-07
- **Primary completion:** 2026-09-30
- **Final completion:** 2027-01-31
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2026-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05300464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05300464, "A Clinical Investigation to Confirm the Ability of MammoWave in Breast Lesions Detection". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT05300464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*